Managing plasma cell leukemia.
Gertz
Morie A
MA
Mayo Clinic, Rochester, Minnesota 55905, USA. gertm@mayo.edu
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D018740:Genetic Heterogeneity / Q000187:drug effects; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000188:drug therapy* / Q000235:genetics; D013792:Thalidomide / Q000627:therapeutic use; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D013792:Thalidomide